AbbVie Inc.Financials
Period:
Currency:
Units:
'09
'13
'17
'21
'25
Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | Dec 16 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 | 45,804 | 33,266 | 32,753 | 28,216 | 25,638 |
Revenue % Change | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% | 37.69% | 1.57% | 16.08% | 10.06% | 12.16% |
Cost of Revenue | 9,965 | 16,904 | 20,415 | 17,414 | 17,446 | 15,387 | 7,439 | 7,718 | 7,040 | 5,833 |
Gross Profit | 51,195 | 39,430 | 33,903 | 40,640 | 38,751 | 30,417 | 25,827 | 25,035 | 21,176 | 19,805 |
Gross Profit % Change | 29.84% | 16.30% | -16.58% | 4.87% | 27.40% | 17.77% | 3.16% | 18.22% | 6.92% | 7.88% |
Gross Profit Margin | 83.71% | 69.99% | 62.42% | 70.00% | 68.96% | 66.41% | 77.64% | 76.44% | 75.05% | 77.25% |
R&D Expenses | 9,096 | 12,791 | 7,675 | 6,510 | 8,046 | 7,755 | 6,792 | 10,753 | 5,334 | 4,585 |
Selling, General, & Admin Expenses | 14,010 | 14,752 | 12,872 | 15,260 | 12,349 | 11,299 | 6,942 | 7,399 | 6,295 | 5,881 |
Other Expenses | 6,875 | 2,750 | 599 | 753 | 432 | -890 | 500 | |||
Operating Income | 21,214 | 9,137 | 12,757 | 18,117 | 17,924 | 11,363 | 12,983 | 6,383 | 9,545 | 9,340 |
Operating Income % Change | 132.18% | -28.38% | -29.59% | 1.08% | 57.74% | -12.48% | 103.40% | -33.13% | 2.19% | 23.92% |
Operating Income Margin | 34.69% | 16.22% | 23.49% | 31.21% | 31.89% | 24.81% | 39.03% | 19.49% | 33.83% | 36.43% |
Total Other Income/Expenses Net | -14,617 | -5,421 | -6,507 | -4,640 | -4,935 | -7,965 | -4,557 | -1,186 | -1,818 | -1,456 |
Income Before Tax | 6,597 | 3,716 | 6,250 | 13,477 | 12,989 | 3,398 | 8,426 | 5,197 | 7,727 | 7,884 |
Income Before Tax % Change | 77.53% | -40.54% | -53.62% | 3.76% | 282.25% | -59.67% | 62.13% | -32.74% | -1.99% | 18.65% |
Income Before Tax Margin | 10.79% | 6.60% | 11.51% | 23.21% | 23.11% | 7.42% | 25.33% | 15.87% | 27.39% | 30.75% |
Income Tax Expense | 2,364 | -570 | 1,377 | 1,632 | 1,440 | -1,224 | 544 | -490 | 2,418 | 1,931 |
Net Income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 | 4,616 | 7,882 | 5,687 | 5,309 | 5,953 |
Net Income % Change | -1.22% | -12.03% | -58.91% | 2.55% | 150.04% | -41.44% | 38.60% | 7.12% | -10.82% | 15.73% |
Net Income Margin | 6.91% | 7.59% | 8.95% | 20.39% | 20.54% | 10.08% | 23.69% | 17.36% | 18.82% | 23.22% |
Weighted Avg. Shares Out | 1,790.68 | 1,769 | 1,768 | 1,771 | 1,770 | 1,667 | 1,481 | 1,541 | 1,596 | 1,622 |
EPS | 2.38 | 2.40 | 2.73 | 6.65 | 6.48 | 2.73 | 5.30 | 3.69 | 3.31 | 3.65 |
EPS % Change | -0.83% | -12.09% | -58.95% | 2.62% | 137.36% | -48.49% | 43.63% | 11.48% | -9.32% | 15.87% |
Weighted Avg. Shares Out Dil | 1,790.68 | 1,773 | 1,773 | 1,778 | 1,777 | 1,673 | 1,484 | 1,546 | 1,603 | 1,631 |
EPS Diluted | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 | 2.72 | 5.28 | 3.68 | 3.30 | 3.63 |
Diluted EPS % Change | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% | -48.48% | 43.48% | 11.52% | -9.09% | 15.97% |
Net Income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 | 4,616 | 7,882 | 5,687 | 5,309 | 5,953 |
Income Tax Expense | 2,364 | -570 | 1,377 | 1,632 | 1,440 | -1,224 | 544 | -490 | 2,418 | 1,931 |
Interest Income | 648 | 540 | 186 | 39 | 174 | 275 | 204 | 146 | 82 | |
Interest Expense | 2,627 | 2,808 | 2,224 | 2,230 | 2,423 | 2,454 | 1,784 | 1,348 | 1,150 | 1,047 |
EBIT | 3,970 | 1,556 | 4,566 | 11,433 | 10,605 | 1,118 | 6,917 | 4,053 | 6,723 | 6,919 |
EBIT % Change | 155.14% | -65.92% | -60.06% | 7.81% | 848.57% | -83.84% | 70.66% | -39.71% | -2.83% | 16.11% |
EBIT Margin | 6.49% | 2.76% | 8.41% | 19.69% | 18.87% | 2.44% | 20.79% | 12.37% | 23.83% | 26.99% |
Depreciation & Amortization | 19,069.67 | 8,386 | 8,698 | 8,467 | 8,521 | 6,471 | 2,017 | 1,765 | 1,501 | 1,189 |
EBITDA | 23,039.67 | 9,942 | 13,264 | 19,900 | 19,126 | 7,589 | 8,934 | 5,818 | 8,224 | 8,108 |
EBITDA % Change | 131.74% | -25.05% | -33.35% | 4.05% | 152.02% | -15.05% | 53.56% | -29.26% | 1.43% | 19.32% |
EBITDA Margin | 37.67% | 17.65% | 24.42% | 34.28% | 34.03% | 16.57% | 26.86% | 17.76% | 29.15% | 31.62% |